Synopsis of recent research by authors named "Rochelle Lear"
- Rochelle Lear's recent research primarily focuses on the development and application of oncolytic viruses and CAR T cell therapies for the treatment of solid tumors, addressing challenges presented by the tumor microenvironment and immune response.
- In her 2022 article, she discusses the promising synergy between T-SIGn tumor reengineering therapy and CAR T cells, demonstrating effective clearance of lung tumor xenografts in animal models, highlighting the potential of combining therapies for improved treatment outcomes.
- Previous studies by Lear also emphasize the use of radiopharmaceuticals, such as 99mTc-NC100668, for imaging venous thromboembolism, showcasing her broad expertise in translational research aimed at enhancing cancer diagnostics and therapeutics.
